Policy
Potential Inequities in New Medical Technologies
Even if we solve the ethical questions about using breakthrough techniques such as CRISPR, will all patients have equal access?
Stories by Jonathan Marron
Jonathan Marron, MD, MPH, is a pediatric oncologist and researcher at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and a member of the teaching faculty at the Harvard Medical School Center for Bioethics.
